Investigators
Study information
- Research Area: Covid-19
- Research type: Clinical Trial
- Start date: Jan 01, 2021
- End date: Dec 31, 2021
Study aim of the objectives
The purpose of this study is to assess the efficacy and safety of Prothione™ capsules administered orally
twice a day for 30 days in subjects with mild to moderate COVID-19.
Study setting/Area (Location)
COVID-19 Treatment Centres
Implementing institution
Rinda Ubuzima, RBC
Department/Division
RIDS
Impact on Policy
To inform guideline on treatment of COVID-19 patients